Financials
Financial year 2025
PRIMIX BIO VENTURES from Kortenberg, company number BE0476755691, closed financial year 2025 with a result of € 106,274 after tax. For that financial year PRIMIX BIO VENTURES recorded a gross margin of € 172,266 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 195,337 to € 106,274. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
€ 1.2 million
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 106,274
▼ 46% vs 2024
Profit after tax over the fiscal year.
€ 93,463
▼ 79% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.2 million.
People and assets in 2025
€ 148,975
▼ 3% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 14,063
▲ 41% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 48,691
▲ 105% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 163,419 | € 56,958 | € 250,357 | € 172,266 | ▼ 31% |
| Profit after taxes | € 109,862 | € 37,368 | € 195,337 | € 106,274 | ▼ 46% |
| Equity | € 875,928 | € 913,296 | € 1,108,634 | € 1,214,908 | ▲ 10% |
| Total debts | € 51,639 | € 29,597 | € 69,177 | € 65,473 | ▼ 5% |
| Cash | € 184,085 | € 218,096 | € 447,791 | € 93,463 | ▼ 79% |
| Retained profit | € 857,328 | € 894,696 | € 1,090,034 | € 1,196,308 | ▲ 10% |
| Balance sheet total | € 927,567 | € 942,894 | € 1,177,811 | € 1,280,381 | ▲ 9% |
Key figures of PRIMIX BIO VENTURES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PRIMIX BIO VENTURES?
What happened at PRIMIX BIO VENTURES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 106,274 (▼ 46% vs 2024). Source: NBB ↗
- New establishment in Kortenberg. KBO
- Start of the company according to the CBE. KBO
In short
From € 109,862 profit in 2022 to € 106,274 profit in 2025.
Paid € 213,581 in corporate taxes since 2022.
Best year ever: 2024, with € 195,337 profit.
Management
Behind PRIMIX BIO VENTURES are Laurence Peeters and Luc Dochez.
Directors
According to the 2025 annual accounts
Laurence Peeters
Director
Luc Dochez
Director
Establishments
Establishment units
Physical locations of this company
Klein Vilvoordestraat 8
3078 Kortenberg
Engelbert Moensstraat 30 A
3078 Kortenberg
Active since 20 February 2002
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0476.755.691
- VAT number
- BE 0476.755.691
- Registered office
- Klein Vilvoordestraat 8, 3078 Kortenberg
- Names & denominations
- PRIMIX BIO VENTURES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 January 2002
- Peppol
- Active · Active since 1 Dec 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied